StockTipsArenaBeta

BUY Gland Pharma Limited — ICICI Securities

BUYGland Pharma Limited
Gland Pharma share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)29 Jan 2026via Institutional / Brokerage Research

Entry₹1,800.1Inferred
Target₹2,275
Total upside +26.38% (call closed)
Stop lossNot given
Exit₹2,27520 May 2026, 12:05 pm
Target hit+26.38%0.00%upside left
Follow ICICI Securities for new calls(67% target hit, 1026 closed calls)Get alertsWatch GLAND for new buy/sell callsGet alertsSee 8 active Long-term calls on GLANDSee 214 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 11:42 pm IST
2 supporting2 neutral0 opposing
Supports the BUY call (2)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·20 May · today

1 other SEBI-registered advisor has an active long-term BUY call on this stock

Advisor consensus · same horizon·4 Nov · 7mo ago

Neutral / worth noting (2)

Press Release on Q4FY26 Audited Financial Results

BSE · Company Update·15 May · 4d ago

(opens in new tab)

Gland Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

NSE · Outcome of Board Meeting·15 May · 4d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Gland Pharma

All analyst calls on Gland Pharma

More from ICICI Securities

Every call and its outcome